(MAR) Marriott International - Overview
Stock: Hotels, Residences, Timeshares, Franchises, Licenses
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.99% |
| Yield on Cost 5y | 2.12% |
| Yield CAGR 5y | 38.21% |
| Payout Consistency | 47.5% |
| Payout Ratio | 35.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 23.2% |
| Relative Tail Risk | -4.42% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.36 |
| Alpha | -1.33 |
| Character TTM | |
|---|---|
| Beta | 1.066 |
| Beta Downside | 1.037 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.50% |
| CAGR/Max DD | 0.86 |
Description: MAR Marriott International January 27, 2026
Marriott International (NASDAQ: MAR) is a global hospitality company that owns, franchises, and licenses a portfolio of more than 30 brands spanning luxury (e.g., The Ritz-Carlton, St. Regis), premium (e.g., Marriott Hotels, Sheraton), and select-service segments (e.g., Courtyard, Fairfield). Its operations include hotels, residential apartments, timeshares, and ancillary assets such as yachts, serving travelers in over 130 countries from its headquarters in Bethesda, Maryland.
In fiscal 2025 Marriott reported a 9.2% year-over-year increase in global RevPAR (Revenue per Available Room) to $115, driven by a 3.8% rise in average daily rate (ADR) and a 5.5% lift in occupancy. The company’s pipeline now includes roughly 1,200 openings slated for 2026-2028, with a particular focus on expanding its luxury and lifestyle brands in high-growth markets such as China, the Middle East, and secondary U.S. cities.
Key macro-economic drivers for Marriott’s outlook include: (1) a projected 3.4% annual growth in global discretionary travel spending, supported by rising middle-class incomes in emerging economies; (2) a gradual recovery in corporate travel volumes, which are expected to rebound to 78% of pre-pandemic levels by 2027 as remote-work policies stabilize; and (3) the U.S. Federal Reserve’s policy trajectory, where a moderate easing of interest rates could lower financing costs for new hotel development and improve consumer confidence.
For a deeper, data-driven assessment of Marriott’s valuation metrics, you may find ValueRay’s analytical tools useful.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 2.61b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -2.11 > 1.0 |
| NWC/Revenue: -18.08% < 20% (prev -19.97%; Δ 1.89% < -1%) |
| CFO/TA 0.10 > 3% & CFO 2.70b > Net Income 2.61b |
| Net Debt (16.21b) to EBITDA (4.71b): 3.44 < 3 |
| Current Ratio: 0.47 > 1.5 & < 3 |
| Outstanding Shares: last quarter (272.7m) vs 12m ago -3.14% < -2% |
| Gross Margin: 21.68% > 18% (prev 0.20%; Δ 2147 % > 0.5%) |
| Asset Turnover: 95.94% > 50% (prev 94.49%; Δ 1.45% > 0%) |
| Interest Coverage Ratio: 5.37 > 6 (EBITDA TTM 4.71b / Interest Expense TTM 781.0m) |
Altman Z'' 2.66
| A: -0.17 (Total Current Assets 4.11b - Total Current Liabilities 8.80b) / Total Assets 27.83b |
| B: 0.65 (Retained Earnings 18.15b / Total Assets 27.83b) |
| C: 0.16 (EBIT TTM 4.19b / Avg Total Assets 27.02b) |
| D: 0.56 (Book Value of Equity 17.48b / Total Liabilities 30.95b) |
| Altman-Z'' Score: 2.66 = A |
Beneish M -3.05
| DSRI: 1.01 (Receivables 3.10b/2.92b, Revenue 25.93b/24.77b) |
| GMI: 0.94 (GM 21.68% / 20.47%) |
| AQI: 0.98 (AQ_t 0.75 / AQ_t-1 0.77) |
| SGI: 1.05 (Revenue 25.93b / 24.77b) |
| TATA: -0.00 (NI 2.61b - CFO 2.70b) / TA 27.83b) |
| Beneish M-Score: -3.05 (Cap -4..+1) = AA |
What is the price of MAR shares?
Over the past week, the price has changed by +5.69%, over one month by +3.54%, over three months by +18.81% and over the past year by +11.07%.
Is MAR a buy, sell or hold?
- StrongBuy: 8
- Buy: 2
- Hold: 16
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the MAR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 321.5 | -3.5% |
| Analysts Target Price | 321.5 | -3.5% |
| ValueRay Target Price | 407.1 | 22.2% |
MAR Fundamental Data Overview February 07, 2026
P/E Forward = 27.6243
P/S = 12.8917
P/B = 47.4452
P/EG = 1.7358
Revenue TTM = 25.93b USD
EBIT TTM = 4.19b USD
EBITDA TTM = 4.71b USD
Long Term Debt = 14.44b USD (from longTermDebt, last quarter)
Short Term Debt = 1.56b USD (from shortTermDebt, last quarter)
Debt = 16.89b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.21b USD (from netDebt column, last quarter)
Enterprise Value = 104.83b USD (88.62b + Debt 16.89b - CCE 678.0m)
Interest Coverage Ratio = 5.37 (Ebit TTM 4.19b / Interest Expense TTM 781.0m)
EV/FCF = 47.28x (Enterprise Value 104.83b / FCF TTM 2.22b)
FCF Yield = 2.11% (FCF TTM 2.22b / Enterprise Value 104.83b)
FCF Margin = 8.55% (FCF TTM 2.22b / Revenue TTM 25.93b)
Net Margin = 10.07% (Net Income TTM 2.61b / Revenue TTM 25.93b)
Gross Margin = 21.68% ((Revenue TTM 25.93b - Cost of Revenue TTM 20.30b) / Revenue TTM)
Gross Margin QoQ = 21.94% (prev 26.87%)
Tobins Q-Ratio = 3.77 (Enterprise Value 104.83b / Total Assets 27.83b)
Interest Expense / Debt = 1.22% (Interest Expense 206.0m / Debt 16.89b)
Taxrate = 26.76% (266.0m / 994.0m)
NOPAT = 3.07b (EBIT 4.19b * (1 - 26.76%))
Current Ratio = 0.47 (Total Current Assets 4.11b / Total Current Liabilities 8.80b)
Debt / Equity = -5.41 (negative equity) (Debt 16.89b / totalStockholderEquity, last quarter -3.12b)
Debt / EBITDA = 3.44 (Net Debt 16.21b / EBITDA 4.71b)
Debt / FCF = 7.31 (Net Debt 16.21b / FCF TTM 2.22b)
Total Stockholder Equity = -3.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.66% (Net Income 2.61b / Total Assets 27.83b)
RoE = -85.31% (negative equity) (Net Income TTM 2.61b / Total Stockholder Equity -3.06b)
RoCE = 36.82% (EBIT 4.19b / Capital Employed (Equity -3.06b + L.T.Debt 14.44b))
RoIC = 25.10% (NOPAT 3.07b / Invested Capital 12.23b)
WACC = 8.41% (E(88.62b)/V(105.50b) * Re(9.84%) + D(16.89b)/V(105.50b) * Rd(1.22%) * (1-Tc(0.27)))
Discount Rate = 9.84% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.96%
[DCF Debug] Terminal Value 77.86% ; FCFF base≈2.39b ; Y1≈2.60b ; Y5≈3.25b
Fair Price DCF = 133.7 (EV 52.08b - Net Debt 16.21b = Equity 35.87b / Shares 268.4m; r=8.41% [WACC]; 5y FCF grow 9.96% → 2.90% )
EPS Correlation: -8.38 | EPS CAGR: -39.77% | SUE: -4.0 | # QB: 0
Revenue Correlation: 85.74 | Revenue CAGR: 10.61% | SUE: 0.36 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.49 | Chg30d=+0.003 | Revisions Net=-1 | Analysts=19
EPS next Year (2026-12-31): EPS=11.43 | Chg30d=+0.061 | Revisions Net=+9 | Growth EPS=+13.1% | Growth Revenue=+5.2%